"The weight loss drug Orlistat is slated to go on sale in European pharmacies without the requirement of a prescription within the next few months. Although early approval was first given several months ago in October 2008, the European Commission has just now given the go ahead for public distribution of the anti-obesity drug, which will be marketed under the name Alli by GlaxoSmithKline, the makers of the product. The estimated price for Alli is GBP1.50 a day." - eCanadaNowThis is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Sunday, January 25, 2009
Non prescription weight loss pill gets European go ahead
"The weight loss drug Orlistat is slated to go on sale in European pharmacies without the requirement of a prescription within the next few months. Although early approval was first given several months ago in October 2008, the European Commission has just now given the go ahead for public distribution of the anti-obesity drug, which will be marketed under the name Alli by GlaxoSmithKline, the makers of the product. The estimated price for Alli is GBP1.50 a day." - eCanadaNow
No comments:
Post a Comment